My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.

    Taja-Chayeb L, Chavez-Blanco A, Martínez-Tlahuel J, González-Fierro A, Candelaria M, Chanona-Vilchis J, Robles E, Dueñas-Gonzalez A.

    Cancer Cell Int. 2006 Oct 2;6:22.PMID: 17014709 [PubMed]Free PMC ArticleFree textRelated citations

    2.

    Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.

    Aoki M, Nabeshima K, Koga K, Hamasaki M, Suzumiya J, Tamura K, Iwasaki H.

    Lab Invest. 2007 Aug;87(8):767-79. Epub 2007 Jun 11.PMID: 17558420 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    3.

    Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression.

    Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F.

    Breast Cancer Res. 2005;7(5):R788-95. Epub 2005 Aug 1.PMID: 16168125 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    4.

    Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.

    Kubo T, Piperdi S, Rosenblum J, Antonescu CR, Chen W, Kim HS, Huvos AG, Sowers R, Meyers PA, Healey JH, Gorlick R.

    Cancer. 2008 May 15;112(10):2119-29.PMID: 18338812 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    5.

    Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.

    Pietras K, Pahler J, Bergers G, Hanahan D.

    PLoS Med. 2008 Jan 29;5(1):e19.PMID: 18232728 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    6.

    PDGF BB induces VEGF secretion in ovarian cancer.

    Matei D, Kelich S, Cao L, Menning N, Emerson RE, Rao J, Jeng MH, Sledge GW.

    Cancer Biol Ther. 2007 Dec;6(12):1951-9. Epub 2007 Sep 1.PMID: 18075302 [PubMed - indexed for MEDLINE]Related citations

    7.

    Combination of imatinib and vinorelbine enhances cell growth inhibition in breast cancer cells via PDGFR beta signalling.

    Weigel MT, Meinhold-Heerlein I, Bauerschlag DO, Schem C, Bauer M, Jonat W, Maass N, Mundhenke C.

    Cancer Lett. 2009 Jan 8;273(1):70-9. Epub 2008 Sep 21.PMID: 18809244 [PubMed - indexed for MEDLINE]Related citations

    8.

    Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo.

    Irsan I, Akisue T, Hara H, Fujimoto T, Imabori M, Doita M, Kuroda R, Fujioka H, Kawamoto T, Yamamoto T, Kurosaka M.

    Anticancer Res. 2007 Jan-Feb;27(1A):423-9.PMID: 17352263 [PubMed - indexed for MEDLINE]Related citations

    9.

    Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.

    van Steensel L, Paridaens D, Schrijver B, Dingjan GM, van Daele PL, van Hagen PM, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA.

    Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3091-8. Epub 2009 Feb 21.PMID: 19234339 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    10.

    Expression, mutational analysis and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors.

    Chu S, Alexiadis M, Fuller PJ.

    Gynecol Oncol. 2008 Jan;108(1):182-90. Epub 2007 Oct 29.PMID: 18028988 [PubMed - indexed for MEDLINE]Related citations

    11.

    Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals.

    Hiraga T, Nakamura H.

    Int J Cancer. 2009 Jan 1;124(1):215-22.PMID: 18814279 [PubMed - indexed for MEDLINE]Related citations

    12.

    Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects.

    Mundhenke C, Weigel MT, Sturner KH, Roesel F, Meinhold-Heerlein I, Bauerschlag DO, Schem C, Hilpert F, Jonat W, Maass N.

    J Cancer Res Clin Oncol. 2008 Dec;134(12):1397-405. Epub 2008 May 9.PMID: 18465140 [PubMed - indexed for MEDLINE]Related citations

    13.

    Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis : a Hoosier Oncology Group trial.

    Matei D, Emerson RE, Schilder J, Menning N, Baldridge LA, Johnson CS, Breen T, McClean J, Stephens D, Whalen C, Sutton G.

    Cancer. 2008 Aug 15;113(4):723-32.PMID: 18618737 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    14.

    Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations.

    Cristofanilli M, Morandi P, Krishnamurthy S, Reuben JM, Lee BN, Francis D, Booser DJ, Green MC, Arun BK, Pusztai L, Lopez A, Islam R, Valero V, Hortobagyi GN.

    Ann Oncol. 2008 Oct;19(10):1713-9. Epub 2008 May 29.PMID: 18515258 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

    15.

    Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment.

    Brama M, Basciani S, Cherubini S, Mariani S, Migliaccio S, Arizzi M, Rosano G, Spera G, Gnessi L.

    Endocr Relat Cancer. 2007 Mar;14(1):61-72.PMID: 17395975 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    16.

    Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature.

    Wcislo G, Szarlej-Wcislo K, Szczylik C.

    J Cancer Res Clin Oncol. 2007 Aug;133(8):533-8. Epub 2007 Apr 24. Review.PMID: 17453242 [PubMed - indexed for MEDLINE]Related citations

    17.

    Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura.

    De Pas T, Toffalorio F, Colombo P, Trifirò G, Pelosi G, Vigna PD, Manzotti M, Agostini M, de Braud F.

    J Thorac Oncol. 2008 Aug;3(8):938-41.PMID: 18670317 [PubMed - indexed for MEDLINE]Related citations

    18.

    Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.

    Perros F, Montani D, Dorfmüller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Hervé P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M.

    Am J Respir Crit Care Med. 2008 Jul 1;178(1):81-8. Epub 2008 Apr 17.PMID: 18420966 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    19.

    The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells.

    Matei D, Satpathy M, Cao L, Lai YC, Nakshatri H, Donner DB.

    J Biol Chem. 2007 Jan 5;282(1):445-53. Epub 2006 Nov 1.PMID: 17079230 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

    20.

    Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models.

    McDowell HP, Meco D, Riccardi A, Tanno B, Berardi AC, Raschellà G, Riccardi R, Dominici C.

    Int J Cancer. 2007 Mar 1;120(5):1141-9.PMID: 17131346 [PubMed - indexed for MEDLINE]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk